Note the time zone of the Virtual Congress is Eastern Daylight Time (EDT, UTC-4)
Please use the arrow to scroll right for additional sessions
The viewing of sessions, cannot be accessed from this conference calendar. All sessions are accessible via the Virtual Platform
Session Type
Industry Symposium
Date
Fri, 10/22/21
Session Time
05:30 PM - 06:30 PM
Session Description
Session Deacription: As immunotherapy availability is increasing around the world, there are a number of Paediatric Oncologists who may benefit from discussing practical clinical aspects with experienced specialists on the use of dinutuximab beta. After a brief introduction the session will be dedicated to answer questions from the audience (either through direct Q&A or using clinical cases).
Practical considerations when using dinutuximab beta as immunotherapy for high risk neuroblastoma
Session Type
Industry Symposium
Date
Fri, 10/22/21
Session Time
05:30 PM - 06:30 PM
Lecture Time
05:30 PM - 05:30 PM
Supported By EUSA PHARMA
Session Type
Industry Symposium
Date
Fri, 10/22/21
Session Time
05:30 PM - 06:30 PM
Lecture Time
05:30 PM - 05:30 PM
Highlights on the use of dinutuximab beta in high risk neuroblastoma
Session Type
Industry Symposium
Date
Fri, 10/22/21
Session Time
05:30 PM - 06:30 PM
Presenter
- Alexandra Wieczorek
Lecture Time
05:30 PM - 06:00 PM
Q&A / Clinical Cases
Session Type
Industry Symposium
Date
Fri, 10/22/21
Session Time
05:30 PM - 06:30 PM
Presenter
- Alexandra Wieczorek
- Giuseppe Barone (United Kingdom)
Lecture Time
06:00 PM - 06:30 PM